Insights on the North American Preventive Inhaler Market to 2019 | Industry Statistics, Emerging Demands, Forecast to 2025

The North American preventive inhaler market was $3.5 billion in 2018 and is anticipated to grow at a substantial rate of 1.0% during the forecast period. The major factors that are contributing significantly to the market growth include rising air pollution, growing geriatric population, and high healthcare expenditure. The US and Canada are the major economies of North America. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors augmenting the growth of the inhaler market in the North America region. The increasing demand for inhaler due to increasing COPD and asthma patients in the US has endorsed the approval of cohesive reimbursement policies in the US, is further fueling the growth of the market. The US is the major market due to greater healthcare expenditure and a higher prevalence rate of respiratory diseases.

To Request a Sample of our Report on North American Preventive Inhaler Market:  https://www.omrglobal.com/request-sample/north-american-preventive-inhaler-market

The North American preventive inhaler market is segmented on the basis of device type, application, and end-user. On the basis of device type, the market is sub-segmented into the metered dosed inhaler and dry powdered inhaler. The dry powder inhaler is estimated to have the largest market share in the North American preventive inhaler market due to providing an easy inhalation solution. Whereas, the market for metered dose inhaler is estimated to be the fastest-growing at a CAGR during the forecast period owing to innovations and collaborations by the companies for the development of metered dosed inhaler. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed. 

(Get 15% Discount on Buying this Report)

A full Report of North American Preventive Inhaler Market is Available @  https://www.omrglobal.com/industry-reports/north-american-preventive-inhaler-market

North American Preventive Inhaler Market Segmentation

By Device Type

·        Metered Dose Inhaler

·        Dry Powder Inhaler

By Application

·        Asthma 

·        Chronic Obstructive Pulmonary Disease (COPD)

By End-User

·        Homecare

·        Hospitals and Clinics

Regional Analysis

·        US

·        Canada

Company Profiles

·        3M Co.

·        Acorda Therapeutics, Inc.

·        Adamis Pharmaceuticals Corp.

·        Adherium Ltd.

·        Aradigm Corp.

·        AstraZeneca PLC

·        Boehringer Ingelheim International GmbH

·        Drive Devilbiss Healthcare LLC

·        GlaxoSmithKline PLC

·        Koninklijke Philips N.V.

·        Manta Devices LLC

·        Novartis AG

·        Omron Healthcare Inc.

·        ResMed Corp.

·        Pulmatrix Inc.

·        Savara, Inc.

·        Sunovion Pharmaceuticals

·        Teva Pharmaceuticals Industries Ltd.

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404